Singapore

Preventing Wnt from hitching a ride may offer new avenue for novel treatments for cancer and fibrosis.

The SNEC 15th (2021) International Photovoltaic Power Generation and Smart Energy Conference will be held on June 2-4, 2021 in Shanghai, China.

New collaboration between Japan’s RIKEN Center for Computational Science (R-CCS), Research Organization for Information Science and Technology (RIST) and National Supercomputing Centre (NSCC) Singapore, will allow Singapore scientists to directly tap on Japan’s Fugaku supercomputer to do ground breaking research, enhance educational activities and develop talent in high performance computing (HPC).

Cell ID Pte. Ltd., a Singapore-incorporated med-tech company, is selling a palm-sized portable genetic test kit that uses an app on a laptop to detect, anywhere, at any time, if a person has COVID-19.

Taskforce will look into COVID-19 origins, leveraging expertise in One Health, outbreak investigation, virology, lab biosecurity and disease ecology.

Cancer is a disease driven by mutations that alter the way biochemical signals control cell growth, division and migration. Scientists at Duke-NUS Medical School found out that, like Goldilocks, cancer is very picky about getting rapid growth just right.

Thirty Teams Across the Asia Pacific Region Participated in the Six-Month Competition that Trains Student Teams to Practice and Produce Solutions using HPC and AI Platforms.

A Duke-NUS Medical School study finds that new labels may be needed to help consumers make healthier food purchases.

A Singapore study finds patients with chronic kidney disease need tailored nutrition guidance, as well as better communication with doctors and family support, to empower them to manage their condition.

Testing for mutations in RNF43, a protein that affects key cancer cell-growth pathway Wnt, gives clinicians actionable insights to tailor treatments better.

Innovative research by scientists at Duke-NUS Medical School has shed light on the mysterious role of long non-coding RNAs in the development of pancreatic cancer and suggests potential new targets for precision cancer therapies.

Maternal antibodies primed to react to specific allergens can cross the placenta, passing on transiently allergic reactions to offspring, according to new preclinical research from a collaborative study by the Agency for Science, Technology and Research, KK Women’s and Children’s Hospital, and Duke-NUS Medical School in Singapore. The finding hints at why infants exhibit allergies so early in life and suggests possible targets for intervention.

Study confirms bats adopt multiple strategies to reduce pro-inflammatory responses, thus mitigating potential immune-mediated tissue damage and disease. Findings provide important insights for medical research on human diseases.

Collaboration by researchers in Singapore and Australia lead to first-of-its-kind computational biology algorithm that could enable more effective cellular therapies against major diseases.

Separate partnership with National Supercomputing Centre to enable Singapore Polytechnic’s staff and students to develop AI innovations for local industries

An anticipated 100+ expert speakers from around the world will convene to discuss next-generation identity solutions and their capability to both transform society and counter identity-based fraud.

New centre launched by SingHealth–Duke-NUS to marshal expertise in prehospital emergency research to ensure best possible patient outcomes.

Conference will see leading regional thought leaders, policymakers, C-suite officers, senior and middle level hospital and healthcare, e-health, clinical operations, medical and nursing professionals convene to explore new ways to innovate and collaborate.

Study by researchers at Duke-NUS Medical School, Duke University and SingHealth finds that dispatch-assisted CPR, training in CPR and use of an Automated External Defibrillator, and a volunteer first responder mobile app, increased the likelihood of laypeople performing CPR during out-of-hospital cardiac arrest, which was associated with increased survival rates.

Forty-five of the world’s most influential leaders and innovators participated in EmTech Asia. They discussed how emerging technologies will influence industries related to artificial intelligence, robotics, sustainability, healthcare, immersive media, and more.

Community rehabilitation; psychological impact of caregiving emerges as top interests

In a May 2020 Webinar, Dr. Sam Shah, Global Digital Health Advisor and Consultant with UK’s National Health System (NHS) discusses how the COVID-19 pandemic is reshaping healthcare with technology, specifically the response of UK’s NHS.

Epstein-Barr virus rewires host epigenome to turn on latent genetic enhancers that activate proto-oncogenes, leading to tumorigenesis in stomach cancer

Jointly organised by the Agency for Science, Technology and Research (A*STAR) and Science Centre Singapore

A simple, rapid assay­­ to evaluate neutralizing antibodies that target the SARS-CoV-2 spike protein receptor binding domain (RBD) is described in a paper published in Nature Biotechnology.

– Human dosing of LUNAR-COV19 expected soon. – Differentiated STARR™ mRNA vaccine expected to produce humoral and cellular immunity at very low doses. – New preclinical data demonstrates neutralising antibody titres continue to increase for 50 days after a single administration.

Thursday, 21 May 2020, 4:00 PM (GMT +8)

Announcement of Results

As a first-in-the-world "rapid smart test kit", the cPass™ which can measure neutralising antibodies in an hour will be a huge boost to current COVID-19 investigations, from contact tracing, sero-prevalence survey, and assessment of herd immunity, longevity of protective immunity and efficacy of different vaccine candidates.

Singapore's National Supercomputing Centre fast track access for researchers involved in COVID-19 research. Applications are open from now until 23 September 2020.